Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Net Margin (2021 - 2026)

Core Scientific has reported Net Margin over the past 6 years, most recently at 301.26% for Q1 2026.

  • Quarterly results put Net Margin at 301.26% for Q1 2026, down 102588.0% from a year ago — trailing twelve months through Mar 2026 was 341.68% (down 8073.0% YoY), and the annual figure for FY2025 was 90.47%, up 19110.0%.
  • Net Margin reached 301.26% in Q1 2026 per CORZ's latest filing, down from 270.77% in the prior quarter.
  • Across five years, Net Margin topped out at 724.62% in Q1 2025 and bottomed at 1191.49% in Q2 2025.
  • Median Net Margin over the past 5 years was 242.16% (2022), compared with a mean of 207.37%.
  • The largest annual shift saw Net Margin skyrocketed 60710bps in 2025 before it plummeted -102588bps in 2026.
  • Over 5 years, Net Margin stood at 358.64% in 2022, then soared by 62bps to 137.88% in 2023, then plummeted by -122bps to 306.71% in 2024, then surged by 188bps to 270.77% in 2025, then crashed by -211bps to 301.26% in 2026.
  • Business Quant data shows Net Margin for CORZ at 301.26% in Q1 2026, 270.77% in Q4 2025, and 177.55% in Q3 2025.